ArticleInternational orthopaedics2026
Five-year implant-related complication rates of total hip arthroplasty performed for osteonecrosis were not improved by robotic-assisted or computer-navigated techniques.
Article in International orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundOsteonecrosis of the femoral head (ONFH) is associated with hip deformity and variable bone quality compared with osteoarthritis (OA). We hypothesised that robotic and navigation-assisted total hip replacement (rTHA, nTHA, together referred to as r-nTHA) might have benefits for this indication.
methodsA national administrative database was used to identify THA patients diagnosed with ONFH or OA. The use of r-nTHA versus manual THA (mTHA) was trended and compared by indication. In THA for ONFH patients, cases with rTHA or nTHA were separately matched to mTHA 1:4 by age, sex, Elixhauser comorbidity index, and surgery year. The 90-day medical adverse events were assessed relative to mTHA. Five-year implant-related complications were compared for those with laterality indicators.
resultsThe utilisation of r-nTHA for ONFH was similar to that for OA until 2021, and lagged behind in 2022 (17.8% versus 23.1%, p = 0.0217). After matching and relative to mTHA, rTHA showed higher odds ratios (OR) for transfusions (OR = 2.67) and readmissions (OR = 2.14), whereas nTHA demonstrated lower OR for adverse events and emergency department visits (ORs 0.48 to 0.67) (p < 0.001 for each). The five-year odds of each of the assessed implant-related complications was comparable between both rTHA and nTHA relative to mTHA.
conclusionsAs implant-related complications were similar between rTHA, nTHA, and mTHA at midterm follow-up, the current study does not provide clear evidence favouring routine use of the technology-assistance over mTHA for ONFH, although cost-effectiveness, surgeon experience, and the potential for increased accuracy in component positioning in anatomically complex cases were not assessed. Prospective studies accounting for ONFH aetiology and disease severity are needed before definitive recommendations can be made. The association of some 90-day outcomes with r-nTHA may be correlated with the pathologies associated with ONFH.
Indexed as
Identifiers
42839053What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.